Sigmoid adenocarcinoma treatment cost in India typically involves a PET/CT scan running Price on request to Price on request and a primary surgery like a colectomy, which costs between AUD $7,767 and AUD $16,241. Total expenses depend on the cancer stage, surgical approach, and clinic choice. Patients generally save around 60–80% compared to Australia and Western Europe. Top cities for this treatment include Bengaluru, Mumbai, and Delhi.
Typical Sigmoid Adenocarcinoma Treatment Costs in India
Bookimed Expert Insight: Patients requiring complex surgical intervention benefit from high-volume centres. Experienced surgeons like Dr. Raj Nagarkar have performed over 50,000 cancer surgeries. For those seeking advanced precision, Fortis Gurgaon uses the Da Vinci robotic system for minimally invasive resections. Clinics such as Global Hospital Mumbai specialise in robotic gastrointestinal surgery. This ensures smaller incisions and quicker recovery for international patients.
| India | Thailand | Turkey | |
| Radiation therapy for colorectal cancer | from AUD $4,519 | from AUD $7,767 | from AUD $9,886 |
| Colectomy (large bowel resection) | from AUD $7,767 | from AUD $16,947 | from AUD $19,065 |
| Chemotherapy for breast cancer | from AUD $4,943 | from AUD $4,237 | from AUD $1,695 |
No hidden fees – just official clinic prices. Pay at the clinic for Sigmoid adenocarcinoma treatment and use a flexible instalment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Sigmoid adenocarcinoma treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Sigmoid adenocarcinoma treatment journey.
The doctor graduated with a Bachelor of Medicine from Mysore University in 1996, followed by a Doctor of Medicine in radiotherapy from Banaras Hindu University in 2002. Further enhancing expertise, the doctor earned a Diplomate of National Board in radiotherapy in 2004.
The doctor is a member of several prestigious organizations, including the Association of Radiation Oncology of India, the Society for Neuro-Oncology, the Bangalore Oncology Group, and the Indian Association of Hyperthermia Oncology, reflecting a strong commitment to advancing the field of oncology.
Professor Raj Nagarkar has performed over 50,000 cancer surgeries and holds a prestigious fellowship from the Royal College of Surgeons, Edinburgh.
Dr Ajit Pai leads the gastrointestinal oncology team at Apollo Hospital, focus on keyhole surgery for bowel and rectal cancers.
Surgical resection is the primary treatment for sigmoid adenocarcinoma in India. Surgeons remove the affected bowel segment to eliminate the tumour. Advanced centres like HCG Manavata and Apollo Indraprastha routinely use laparoscopic or robotic-assisted techniques. These offer faster recovery and greater precision.
Bookimed Expert Insight: Indian oncology centres demonstrate exceptional surgical experience. Prof. Dr Raj Nagarkar at HCG Manavata alone has performed over 50,000 cancer surgeries. High surgery volumes and JCI and NABH accreditations at clinics like Apollo and Manipal ensure expertise that rivals top Western institutions. Costs are significantly lower.
Patient Consensus: Patients in India emphasise the importance of multi-disciplinary tumour boards in Delhi and Mumbai. These boards are essential for deciding whether to start with surgery or chemotherapy. They note that completing the full chemotherapy regimen is critical for long-term survival. This is especially important in advanced stages.
India offers treatment for sigmoid adenocarcinoma at JCI-accredited facilities like Apollo Hospital Indraprastha and HCG Manavata Cancer Centre. These hospitals specialise in robotic-assisted colectomies and laparoscopic resections. Leading oncology units use PET-CT imaging and multidisciplinary teams to manage complex colorectal cases.
Bookimed Expert Insight: While private hospitals like Apollo and Manipal offer VIP services, HCG Manavata Cancer Centre provides an audited research environment. Their US-FDA audited institute and team of 450+ oncologists process 30,000+ PET scans. This volume suggests a superior diagnostic baseline for staging sigmoid adenocarcinoma accurately.
Patient Consensus: Patients note that Tata Memorial Hospital in Mumbai remains the gold standard for complex gastrointestinal oncology. Those seeking shorter wait times often choose Apollo or Primus in Delhi for dedicated international patient teams.
Patients should plan an initial stay of 2 to 4 weeks in India. This covers sigmoid adenocarcinoma surgery and recovery. The timeframe also allows for diagnostic imaging, the procedure, and post-operative follow-up. Extended stays of 3 to 6 months are necessary. This applies if completing a full chemotherapy course locally.
Bookimed Expert Insight: Indian oncology centres often suggest a split-treatment model for international patients. Patients can complete the major surgery in India at high-volume centres. Manipal Hospitals is one such centre, serving 2,000,000 patients annually. After initial recovery, patients often return home to Australia. They receive chemotherapy under their local GP and specialist. With this approach, patients receive expert surgical care. They also spend less time away from their support network.
Patient Consensus: Patients note that staying roughly 2 weeks covers essential admission and immediate recovery in India. Many emphasise that bringing a family member helps significantly. It assists with daily care and learning recovery protocols before flying.
Medical tourism for sigmoid adenocarcinoma in India is a viable option. Leading Indian hospitals provide JCI-accredited care and technologies like robotic-assisted surgery and PET-CT. Specialists such as Prof. Dr Raj Nagarkar have performed over 50,000 cancer surgeries. This includes complex colorectal resections.
Bookimed Expert Insight: Clinical experience in India is exceptionally deep. At HCG Manavata Cancer Centre, specialists like Dr Chaitainya Borde have managed over 30,000 PET scans. This high volume helps doctors identify subtle spreads in sigmoid cases. Lower-volume centres might miss these. Most leading Indian oncologists also hold international credentials, such as MRCS from the UK.
Patient Consensus: Patients find that hospital social workers in India are helpful for navigating logistics. They suggest seeking treatment in Delhi NCR or Bengaluru. Many note that outcomes for stage 4 cases improve. This happens when chemotherapy successfully shrinks tumours before surgery. Success often depends on finding a specialist familiar with specific genetic mutations.
A consultation with an Indian oncologist should focus on tumour staging, biomarker testing, and surgical technique. Specialists at centres like Apollo Hospital Indraprastha use JCI-accredited protocols. They determine if chemotherapy or radiotherapy is needed before surgery. Ask about minimally invasive options and multidisciplinary team reviews.
Bookimed Expert Insight: Indian oncology centres often lead in high-volume surgical experience. Dr Raj Nagarkar at HCG Manavata Cancer Centre has performed over 50,000 cancer surgeries. This volume is significant for Australians. It means surgeons here often manage more sigmoid cases in one month. This is more than some regional specialists see in a year.
Patient Consensus: Patients in India recommend asking about biomarker testing immediately. They found that adding targeted drugs to standard chemotherapy significantly improved their results. It also improved their overall treatment experience.